We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Updated: 7/24/2014
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Click here to add this to my saved trials
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/28/2014
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/28/2014
Click here to add this to my saved trials
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/28/2014
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/28/2014
Click here to add this to my saved trials
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Status: Enrolling
Updated: 7/28/2014
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Status: Enrolling
Updated: 7/28/2014
Click here to add this to my saved trials
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Status: Enrolling
Updated: 7/28/2014
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Updated: 7/28/2014
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Status: Enrolling
Updated: 7/28/2014
Click here to add this to my saved trials
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.
Status: Enrolling
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.
Status: Enrolling
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.
Status: Enrolling
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates
Updated: 7/30/2014
Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates.
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
Updated: 7/30/2014
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Updated: 7/30/2014
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 7/30/2014
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Updated: 7/30/2014
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 7/30/2014
Click here to add this to my saved trials
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Click here to add this to my saved trials
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Click here to add this to my saved trials
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Click here to add this to my saved trials
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Click here to add this to my saved trials
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
Status: Enrolling
Updated: 8/1/2014
Updated: 8/1/2014
Click here to add this to my saved trials